Ronald Mancini, MD
NPI 1457307639ActiveIndividual· Ophthalmology, Ophthalmic Plastic and Reconstructive Surgery· Calabasas, CA
Ophthalmology, Ophthalmic Plastic and Reconstructive Surgery (MD) in Calabasas, California, trained at Tufts University School of Medicine (class of 2002). Their prescriptions cost Medicare Part D more than their services did: $371,897 for 250 claims, against $231,449 paid for services in 2024. Biotissue Holdings Inc. was the largest of 5 companies reporting payments in 2025, $453.86 in all, mostly food and beverage.
Overview
| NPI | 1457307639 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | May 26, 2006 |
| Last updated in NPPES | Jul 1, 2025 |
| Certified by provider | Jul 1, 2025 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Ophthalmology, Ophthalmic Plastic and Reconstructive Surgery Primary | 207WX0200X | A94919 | CA |
| Ophthalmology | 207W00000X | A94919 | CA |
| Ophthalmology | 207W00000X | N1386 | TX |
| Ophthalmology, Ophthalmic Plastic and Reconstructive Surgery | 207WX0200X | N1386 | TX |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Ophthalmology (CA); Practitioner - Ophthalmology (TX) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 457 |
|---|---|
| Services billed | 9,759 across 64 procedure codes |
| Paid by Medicare | $231,449 |
Part D prescriptions in 2024
| Prescriptions (claims) | 250 · 274 30-day fills |
|---|---|
| Patients | 146 |
| Total drug cost | $371,897 |
| Generic share | 80% of claims |
Education and affiliations
| Medical school | Tufts University School of Medicine |
|---|---|
| Graduation year | 2002 |
| Medicare specialty | Ophthalmology |
Medical group
- Jules Stein Eye Institute Medical GroupPasadena, CA · 119 clinicians
Hospital affiliation
- Ronald Reagan UCLA Medical CenterLos Angeles, CA
Industry payments (Open Payments)
- 2025$453.86 · 7 payments from 5 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Biotissue Holdings Inc. | $215.70 | 2 |
| Revance Therapeutics, Inc. | $149.37 | 1 |
| Amgen Inc. | $38.47 | 2 |
| Merz Pharmaceuticals, LLC | $34.85 | 1 |
| Harrow Eye, LLC | $15.47 | 1 |
What the 2025 payments were for
- Food and Beverage$453.86 · 7 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records